SilkTech completes patient enrollment for their Phase 2B clinical trial the use of SDP-4 in treating the signs and symptoms of Dry Eye Disease

A total of 305 patients over 25 sites have been enrolled within the SDP-4-CS201 study to assess the use of SDP-4 eye drops in treating the signs and symptoms of Dry Eye Disease. The 3-month dosing study will run through October with top line results expected before the end of 2019. https://clinicaltrials.gov/ct2/show/NCT03889886